[1] Feng RN, Du SS, Wang C, et al. Lean-alcoholic fatty liver disease risk for metabolic disorders in a nomal weight Chinese population [J]. World J Gastroenterol,2014,20(47):17932-40. [2] Leung JC,Loong TC,Wei JL,et al.Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients[J].Hepatology,2017,65(1):54-64. [3] Cusi K.Nonalcoholic steatohepatiti8 in nonobese patients:not so different after all[J]. Hepatology,2017,65(1):4-7. [4] Han X. Lipidomics for studying metabolismJ [J]. Nat Rev Endocrinol, 2016,12(11) :668-680. [5] 中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会.非酒精性脂肪性肝病防治指南(2018更新版)[J].实用肝脏病杂志,2018,21:177-186. [6] Tan EX, Lee JW, Jumat NH, et al. Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study [J]. Metabolism,2022,126:154911. [7] Chiappini F, Coilly A, Kadar H, et al. Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients [J]. Sci Rep, 2017, 24(7):46658. [8] Loomba R, Quehenberger O, Armando A, et al. Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis [J]. J Lipid Res, 2015, 56(1):185-192. [9] Jung Y,Lee MK,Puri P,et al.Circulating lipidomic alterations in obese and non-obese subjects with non-alcoholic fatty liver disease [J]. Aliment Pharmacol Ther,2020,52(10):1603-1614. [10] Veen JN, Kennelly JP, Wan S, et al. The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease [J]. Biochim Biophys Acta Biomembr, 2017,1859(9 Pt B):1558-1572. [11] 曾钗明 , 陈建康 , 李兴华等. 慢性乙型肝炎合并非酒精性脂肪肝的临床和实验室特征 [J]. 中国医学创新 , 2019, 16(35): 136-141. [12] Puri P,Baillie RA,Wiest MM,et al.A lipidomic analysis of nonalcoholic fatty liver disease [J]. Hepatology,2007,46(4):1081-1090. [13] Chew WS, Torta F, Ji S, et al. Large-scale lipidomics identifies associations between plasma sphingolipids and T2DM incidence [J]. JCI Insight,2019,5(13):e126925. [14] Tu LN, Showalter MR, Cajka T, et al. Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice [J]. Sci Rep,2017,7(1):6120. |